Search research articles
Contact Us
Filters
Showing results (351-360 of 409) with videos related to
Page
of 41
Sort By:
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
November 1, 1989
Ascertainment of informative Alzheimer disease families from the IMAGE Project registry for genetic linkage analysis studies
D Gautrin, J Nalbantoglu, G Lacoste-Royal, et al.
Gynecologic Oncology
|
October 8, 2003
Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study
D Belpomme, I Krakowski, M Beauduin, et al.
Clinical Therapeutics
|
February 24, 2001
Rivastigmine for Alzheimer's disease: Canadian interpretation of intermediate outcome measures and cost implications
J F Baladi, P A Bailey, S Black, et al.
International Journal of Geriatric Psychiatry
|
July 24, 2001
Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?
B Winblad, H Brodaty, S Gauthier, et al.
Nanotechnology
|
September 13, 2018
Surface manipulation of a curved polycyclic aromatic hydrocarbon-based nano-vehicle molecule equipped with triptycene wheels
W-H Soe, C Durand, O Guillermet, et al.
Neurobiology of Aging
|
January 1, 1984
CSF acetylcholinesterase in dementia and in sequential samples of lumbar CSF
S Lal, P L Wood, M E Kiely, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
October 28, 2022
Dual-Readout of the Mechanical Response of a Bis-acridinium [2]Rotaxane
Johnny Hu, Sonia Adrouche, Etienne S Gauthier, et al.
Neurology
|
August 29, 2001
Progression of impairment in patients with vascular cognitive impairment without dementia
C Wentzel, K Rockwood, C MacKnight, et al.
Alzheimer Disease and Associated Disorders
|
September 15, 1999
Placebos in clinical trials in Alzheimer disease: an international discussion
P J Whitehouse, R Arizaga, H Brodaty, et al.
Advances in Protein Chemistry
|
May 2, 2001
Pure selective estrogen receptor modulators, new molecules having absolute cell specificity ranging from pure antiestrogenic to complete estrogen-like activities
F Labrie, C Labrie, A Bélanger, et al.
Page
of 41
Search research articles
Search
Showing results (351-360 of 409) with videos related to
Sort By:
Page
of 41
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
November 1, 1989
Ascertainment of informative Alzheimer disease families from the IMAGE Project registry for genetic linkage analysis studies
D Gautrin, J Nalbantoglu, G Lacoste-Royal, et al.
Gynecologic Oncology
|
October 8, 2003
Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study
D Belpomme, I Krakowski, M Beauduin, et al.
Clinical Therapeutics
|
February 24, 2001
Rivastigmine for Alzheimer's disease: Canadian interpretation of intermediate outcome measures and cost implications
J F Baladi, P A Bailey, S Black, et al.
International Journal of Geriatric Psychiatry
|
July 24, 2001
Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?
B Winblad, H Brodaty, S Gauthier, et al.
Nanotechnology
|
September 13, 2018
Surface manipulation of a curved polycyclic aromatic hydrocarbon-based nano-vehicle molecule equipped with triptycene wheels
W-H Soe, C Durand, O Guillermet, et al.
Neurobiology of Aging
|
January 1, 1984
CSF acetylcholinesterase in dementia and in sequential samples of lumbar CSF
S Lal, P L Wood, M E Kiely, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
October 28, 2022
Dual-Readout of the Mechanical Response of a Bis-acridinium [2]Rotaxane
Johnny Hu, Sonia Adrouche, Etienne S Gauthier, et al.
Neurology
|
August 29, 2001
Progression of impairment in patients with vascular cognitive impairment without dementia
C Wentzel, K Rockwood, C MacKnight, et al.
Alzheimer Disease and Associated Disorders
|
September 15, 1999
Placebos in clinical trials in Alzheimer disease: an international discussion
P J Whitehouse, R Arizaga, H Brodaty, et al.
Advances in Protein Chemistry
|
May 2, 2001
Pure selective estrogen receptor modulators, new molecules having absolute cell specificity ranging from pure antiestrogenic to complete estrogen-like activities
F Labrie, C Labrie, A Bélanger, et al.
Page
of 41